Elena Pezzolo

• Pezzolo E,Ciampichini R,Cazzaniga S,Sampietro G,Naldi L,Zucchi A. Psoriasis comorbidity and mortality in Northern Italy: a record-linkage analysis of healthcare databases. (JAAD2019, in press) .
• Pezzolo E, Naldi L. Current Epidemiology of Chronic Inflammatory Skin Diseases. (Expert Rev Clin Immunol 2019 in press).
  
• Gisondi P, Pezzolo E, Girolomoni G. Glomerular filtration rate in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 2019 Feb 18. Doi: 10.111/jdv.155506.
  
• Pezzolo E, Cazzaniga S, Colombo P, Chatenoud L, Naldi L. Psoriasis Incidence and Lifetime Prevalence: Suggestion of a Higher Mortality rate in Older Age-classes among Psoriatic Patients Compared to the General Population in Italy. Acta Derm Venereol. 2019;99(4):400-403. 
  
• Pezzolo E, Naldi L. The relation between smoking, psoriasis and psoriatic arthritis. Expert Rev Clin Immunol 2018 Oct 31:1-8.
  
• Pezzolo E, Mutlu U, Vernooij MW, Dowlatshahi EA, Gisondi P, Girolomoni G, Nijsten T, Ikram MA, Wakkee M. Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study. J Am Acad Dermatol 2018 Aug 6. Doi:10.1016/j.jaad.2018.07.046.
  
• Naldi L, Pezzolo E. Back to the Future: Looking at the Skin to Predict Death-A Lesson from Psoriasis. J Invest Dermatol. 2018;138(1):20-22. 
  
• Pezzolo E, Peroni A, Gisondi P, Girolomoni G. Heat urticaria: a revision of published cases with an update on classification and management.Br J Dermatology. 2016;175(3):473-478.
  
• Gisondi P, Pezzolo E. Doctor-patient communication. Esperienze Dermatologiche. 2015;17(1):39-42. 
  
• Gisondi P, Pezzolo E, Lo Cascio G and Girolomoni G. Latent tuberculosis infection in patients with chronic plaque psoriasis candidate to biological therapy. Br J Dermatol. 2014;171:884-890.
  
• Pezzolo E, Peroni A, Schena D, Girolomoni G. Pre-heated autologous serum skin test in localized heat urticaria. Clinical Experimental Dermatology. 2014;39:921-923.
  
• Pezzolo E, Colato C, Del Giglio M, Tessari G, Girolomoni G. Acantolytic dyskeratotic acanthoma in an immunosuppressed patient: a case report with review of the literature. Clinical Dermatology. 2013;1:149-152.

National and International Posters:

• Pezzolo E, Cazzaniga S, Colombo P, Chatenaud L, Naldi L. Psoriasis incidence and lifetime prevalence: suggestion for a higher mortality rate in older age-classes among psoriatic patients compared to the general population in Italy. European Academy of Dermatology and Venereology (EADV), Madrid. 9-13 October 2019.
  
• Pezzolo E, Cazzaniga S, Colombo P, Chatenaud L, Naldi L. Psoriasis incidence and lifetime  prevalence: suggestion for a higher mortality rate in older age-classes among psoriatic patients compared to the general population in Italy. National Psoriasis Foundation (NPF) Symposium, Seattle. 30-31 May 2019.
  
• Pezzolo E, Mutlu U, Vernooij MW, Dowlatshahi EA, Gisondi P, Girolomoni G, Nijsten T, Ikram MA, Wakkee M. Psoriasis is not associated with cognition, brain imaging markers and risk of dementia: the Rotterdam Study.National Psoriasis Foundation (NPF) Symposium, Chicago. 3-5 August 2017
  
• Pezzolo E, Gisondi P, Girolomoni G. Glomerular filtration rate in patients with moderate-to-severe psoriasis treated with conventional systemic therapies versus biologics.GRAPPA  TRAINEE SYMPOSIUM. Miami. 14-16 July, 2016.
  
• Gisondi P, Pezzolo E, Zaza G, Girolomoni G. Assessment of glomerular filtration rate in patients with psoriasis candidate to systemic treatment. 23rd World Congress of Dermatology, Vancouver. 8-13 June, 2015.
  
• Pezzolo E, Gisondi P, Girolomoni G. Prevalence of Hepatitis C and B virus in patients with plaque psoriasis candidate to biological therapy. 90° congresso nazionale SIDemast, Milano. 22-24th April 2015.
• Pezzolo E, Gisondi P, Curri A, Girolomoni G. Assessment of glomerular filtration rate in patients with psoriasis candidate to systemic treatment. Immunoconvention. Berlin 31th October-1th Nov.  
  
• Pezzolo E, Gisondi P, Sala F, Alessandrini F, Avesani V, Zoccatelli G, Beltramello A, Moretto G, Gambina G, Girolomoni G. MIld cognitive impairment in patients with moderate to severe chronic plaque psoriasis. GRAPPA TRAINESS SYMPOSIUM. New York. 11 July, 2014.
  
• Pezzolo E, Peroni A, Schena D, Girolomoni G. Il test del siero autologo pre-riscaldato nella orticaria localizzata da calore: un caso clinico con revisione della letteratura. 89° congresso nazionale SIDemast. Parma 14-17th May 2014.
  
• Gisondi P, Pezzolo E, Lo Cascio G and Girolomoni G. Prevalence of latent tuberculosis infection in patients with chronic plaque psoriasis screened for biological therapy. Convegno ADIPSO Roma. 10-12th April 2014.
• Gisondi P, Pezzolo E, Lo Cascio G and Girolomoni G. Prevalence of latent tuberculosis infection in patients with chronic plaque psoriasis screened for biological therapy. European Workshop on Skin Immune Mediated Inflammatory Diseases (SIMID) Verona. 24-26th April 2014.
• Pezzolo E, Peroni A, Schena D and Girolomoni G.  Pre-heated autologus serum skin test in localized heat urticaria: a case report with review of the literature. European Workshop on Skin Immune Mediated Inflammatory Diseases (SIMID) Verona. 24-26th April 2014.(Internationational)
  
• Gisondi P, Targher G, Cagalli A, Pezzolo E, Girolomoni G. Hyperuricaemia in patients with chronic plaque psoriasis. European Workshop on Skin Immune Mediated Inflammatory Diseases (SIMID) Verona. 24-26th April 2014.
  
• Pezzolo E, Schena D, Colato C e Girolomoni G. Hot spots. 88° Congresso Nazionale SIDeMaST, Venezia Lido. 15-18th May 2013.
  

National and international conferences (Relator/Moderator):  

• “VIII Nazional congress S.I.Der.P. Paediatric dermatology pediatrica: outcomes and new orizons ”, Abano Terme, 21-23 November 2019 (relator) .
  
• “Immunomediated chronic skin diseases -MICC”, Roma, 14-15 November 2019 (relator).
• “Prevention, treatment and managment of eredo-familiar cancers”, San Gaetano, Padova, 4 October. 2019 (relator) 
• “Update on  the PDTA for patients with melanoma”, San Gaetano, Padova ,11 September 2019 (relator).
• “Annual national meeting of Italian Hospital Dermatologists (ADOI)“, Grosseto 17-20October 2018 (relator).
• “ Diagnosis and Management of Pruritus and Pain in Dermatology”, Vicenza 26-27September 2018 (relator).
• “Meeting GISED. The renaissance of dermatoepidemiology: between Big Data and equal distribution of the resources”,  Firenze, 12 Aprile 2018 (relator).
• “Simposium of the Young Dermatology Italian Network (YDIN)“, Firenze, 11th April 2018 (relator and  moderator).
• “Conference of European Dermato-Epidemiology Network (EDEN) Forum“, Madrid, 30-31st March 2017 (relator).
• “Clinical and economical implications of the treatment of psoriasis”, Roma, 6September2015 elator and moderator). 
• 90° National congress SIDemast, Milano, 22-24 April 2015 (relator).
• Dermatological meetings, Legnago, 19 September 2014 (relator).
• The ciclosporin in dermatology. Verona, 28 March 2014 (relator).
• Meetinf on complex dermopathies, Verona,12June 2014 (relator). 
• 89° National congress SIDemast, Parma, 14-17May 2014 (relator).

National and internationalconferences(Presentation of clinicalcases):

• Idrosadenite 2018: Nuove conoscenze a confronto. Vicenza, 21 April 2018.
• VI Corso Scaligero Dermatologia Pediatrica, Verona, 7 November 2015.
• Seminari dermatologici delle Venezie, Brescia, 25 Settember 2015.
• Seminari dermatologici delle Venezie, Padova, 3 October 2014.
• Seminari Dermatologici delle Venezie, Padova, 22 November 2013.
• V Corso Scaligero di Dermatologia Pediatrica, Verona, 21 September 2013 .
• Seminari Dermatologici delle Venezie, Verona, 16 April 2013.

Honours and awards:

Winner of the best presentation at conference “Cyclosporine in dermatology”, Verona, 28th March 2014.

Member of National/Intenational Societes:

• Italian Society of Dermatology (SIDemast).
• Italian Society of Pediatric dermatology (SIDerp).
• European Academy of Dermatology and Venereology (EADV).
• American Academy of Dermatology (AAD).
• Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
• International Society of Dermatoscopy (ISD).
• European Dermato-Epidemiology Network (EDEN).

Member of Directory Board: 

• Study Group of Italian Dermatology and Epidemiology (GISED).
  

National and International work Groups:

• Board member of the Nail Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment Recommendations Working Group. 
• Systematic review and Meta-analysis of cardio-metabolic comorbidities, all-cause and mortality causes of psoriatic arthritis (PROSPERO Registration 127395), Epidemiology Unit, Bern University, Switzerland.
• Long-term prospective observational safety study TREatment of ATopic eczema (TREAT) Registry Taskforce.
• Regional protocol for a multicentric, randomized and controlled study on the effects of the early treatment of instable psoriasis with IL23-inhibitors vs conventional evidence-based treatment.

Scolarships:

• POSTER PRESENTATION at the National Psoriasis Foundation (NPF) Symposium, Seattle, May 30-31, 2019.
• POSTER PRESENTATION at the National Psoriasis Foundation (NPF) Symposium, Chicago, August 3-5, 2017.
• POSTER PRESENTATION at the GRAPPA TRAINEE SYMPOSIUM, Miami, July 14-16, 2016.
• POSTER PRESENTATION at the GRAPPA TRAINEE SYMPOSIUM, New York, July 11, 2014.

Reviwer of National and International Journals: 

• British Journal of Dermatology.
  
• Journal of Investigative Dermatology.
• Acta dermato Venereologica.
• American Journal of Clinical Dermatology.
• Clinical dermatology.
• Journal of Clinical Psichiatry.